Keynote Speaker Announced for ISPOR Dubai 2018

Published Aug 28, 2018

His Excellency (HE) Dr Amin Al Ameeri of United Arab Emirates Ministry of Health and Prevention to Deliver Keynote

Lawrenceville, NJ, USA—August 28, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced that HE Dr Amin Al Ameeri, MSc, PhD, Assistant Undersecretary for Public Health Policy and Licensing Sector, Ministry of Health and Prevention, United Arab Emirates will deliver the keynote address at the ISPOR Dubai 2018 conference. ISPOR Dubai 2018 will take place on 19-20 September 2018 in Dubai, United Arab Emirates. HE Dr Al Ameeri stated, “The United Arab Emirates Ministry of Health and Prevention welcomes the ISPOR Dubai conference. The theme of the conference is timely and contributes toward cooperation efforts of the many healthcare stakeholders to improve healthcare decisions across the region. By applying health economics and outcomes research to make evidence-based healthcare and policy decisions, we can work together to employ innovative solutions, optimize value in health, and reach the goal of world-class healthcare.” ISPOR Dubai 2018 will be the first regional conference of its type that the Society is organizing and will focus on the theme, “Healthcare Decision Making in the Middle East and North Africa: The Role of Health Economics and Outcomes Research and Health Technology Assessment.” The conference will bring together regional and international experts and stakeholders in HEOR to share innovative research methods and health policy developments. The ISPOR Dubai 2018 program will feature a number of educational seminars, including “Introduction to Health Economics” and “Introduction to Health Technology Assessment.” The plenary session, “The Role of HEOR in Decision Making: Global Knowledge for Local Application,” will draw on the experience of speakers from the United Kingdom, United States, United Arab Emirates, and Egypt. The robust scientific program will cover a diverse mix of regional topics, including 3 panel discussions on “Improving Access to Innovative Health Technologies,” “Pricing and Reimbursement: Issues and Challenges,” and “Health Technology Assessment Implementation Roadmap in the Middle East and North Africa.”

For additional information on ISPOR Dubai 2018, please see: Conference Information | Registration | Exhibit and Sponsorship Opportunities | Supporting Institutions | Press

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

Oct 14, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×